1,233 reports of this reaction
2.9% of all Latuda reports
#3 most reported adverse reaction
ANXIETY is the #3 most commonly reported adverse reaction for Latuda, manufactured by Sumitomo Pharma America, Inc.. There are 1,233 FDA adverse event reports linking Latuda to ANXIETY. This represents approximately 2.9% of all 42,043 adverse event reports for this drug.
Patients taking Latuda who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is a less commonly reported adverse event for Latuda, but still significant enough to appear in the safety profile.
In addition to anxiety, the following adverse reactions have been reported for Latuda:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 1,233 FDA reports for Latuda. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 2.9% of all adverse event reports for Latuda, making it one of the most commonly reported side effect.
If you experience anxiety while taking Latuda, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.